CLINICAL_TRIALS
research
· 2026-01-22
Clinical Trial Update: Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD [NA]
Summary
The LEOPARD trial is evaluating liquid biopsy as a prognostic and response diagnostic tool for Ewing sarcoma (bone and soft tissue), Peripheral primitive neuroe…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Ewing Sarcoma, Ewing Sarcoma of Bone | NA | Status: RECRUITING